We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMU
26
DELISTED
Immunomedics Inc
IMMU
$11.4M 0.55%
133,613
+113,090
+551% +$5.72M
MNTA
27
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11.1M 0.54%
212,323
+196,179
+1,215% +$8.12M
SLV icon
28
PUT
iShares Silver Trust
SLV
$30.7B
$10.3M 0.5%
476,300
+476,100
+238,050% +$10.8M
TIF
29
DELISTED
Tiffany & Co.
TIF
$10.1M 0.49%
87,175
-13,283
-13% -$1.61M
WMGI
30
DELISTED
Wright Medical Group Inc
WMGI
$10M 0.48%
327,645
+137,458
+72% +$4.15M
AMZN icon
31
Amazon
AMZN
$2.96T
$9.91M 0.48%
62,980
-17,460
-22% -$2.75M
TMUS icon
32
T-Mobile US
TMUS
$190B
$8.48M 0.41%
74,183
+3,337
+5% +$370K
PYPL icon
33
PUT
PayPal
PYPL
$50.5B
$8.12M 0.39%
41,200
+40,000
+3,333% +$7.53M
ACIA
34
DELISTED
Acacia Communications Inc
ACIA
$8.09M 0.39%
120,063
+10,309
+9% +$699K
AIMT
35
DELISTED
Aimmune Therapeutics
AIMT
$7.58M 0.37%
+219,893
New +$4.68M
WTW icon
36
Willis Towers Watson
WTW
$32B
$7.38M 0.36%
35,335
+25,872
+273% +$5.28M
JD icon
37
JD.com
JD
$44.5B
$6.93M 0.34%
89,285
+30,987
+53% +$2.15M
VRRM icon
38
Verra Mobility
VRRM
$744M
$6.88M 0.33%
+712,401
New +$7.45M
PTON icon
39
PUT
Peloton Interactive
PTON
$2.49B
$6.55M 0.32%
66,000
+63,900
+3,043% +$4.7M
XRT icon
40
PUT
State Street SPDR S&P Retail ETF
XRT
$327M
$6.46M 0.31%
130,000
+80,000
+160% +$3.92M
HLIT icon
41
Harmonic Inc
HLIT
$1.28B
$6.43M 0.31%
+1,153,091
New +$6.53M
MPC icon
42
Marathon Petroleum
MPC
$83.7B
$6.2M 0.3%
+211,317
New +$7.43M
BILI icon
43
Bilibili
BILI
$7.84B
$6.08M 0.29%
146,203
+69,953
+92% +$3.09M
BA icon
44
CALL
Boeing
BA
$185B
$6.07M 0.29%
36,700
-9,400
-20% -$1.6M
ADSW
45
DELISTED
Advanced Disposal Services Inc
ADSW
$6.06M 0.29%
200,338
+128,897
+180% +$3.89M
CSCO icon
46
CALL
Cisco
CSCO
$479B
$5.91M 0.29%
150,100
+126,500
+536% +$5.51M
MSFT icon
47
Microsoft
MSFT
$3.71T
$5.73M 0.28%
27,242
-9,440
-26% -$1.98M
KBR icon
48
KBR
KBR
$4.8B
$5.56M 0.27%
+248,473
New +$5.76M
TSLA icon
49
CALL
Tesla
TSLA
$1.3T
$5.45M 0.26%
38,100
-174,900
-82% -$20.7M
BYND icon
50
Beyond Meat
BYND
$277M
$5.42M 0.26%
32,626
+5,404
+20% +$732K

Similar funds

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.